These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31620452)

  • 41. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.
    Alagiakrishnan K; Banach M; Jones LG; Datta S; Ahmed A; Aronow WS
    Ann Med; 2013 Feb; 45(1):37-50. PubMed ID: 22413912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    Hunter WG; McGarrah RW; Kelly JP; Khouri MG; Craig DM; Haynes C; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Coll Cardiol; 2019 Jan; 73(2):177-186. PubMed ID: 30654890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
    Steinmann E; Brunner-La Rocca HP; Maeder MT; Kaufmann BA; Pfisterer M; Rickenbacher P
    Eur J Intern Med; 2018 Nov; 57():61-69. PubMed ID: 29908708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction.
    Tanaka K; Valero-Muñoz M; Wilson RM; Essick EE; Fowler CT; Nakamura K; van den Hoff M; Ouchi N; Sam F
    JACC Basic Transl Sci; 2016 Jun; 1(4):207-221. PubMed ID: 27430031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Shah SJ; Kaye DM; Gustafsson F; Hasenfuβ G; Hoendermis E; Litwin SE; Komtebedde J; Lam C; Burkhoff D; Borlaug BA
    J Am Coll Cardiol; 2019 Nov; 74(21):2539-2550. PubMed ID: 31753198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.
    Chen YT; Wong LL; Liew OW; Richards AM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).
    Tschöpe C; Birner C; Böhm M; Bruder O; Frantz S; Luchner A; Maier L; Störk S; Kherad B; Laufs U
    Clin Res Cardiol; 2018 Jan; 107(1):1-19. PubMed ID: 29018938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
    Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
    Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?
    Gupta A; Bailey SR
    Curr Cardiol Rep; 2018 Aug; 20(10):85. PubMed ID: 30112586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort.
    Schwarzl M; Ojeda F; Zeller T; Seiffert M; Becher PM; Munzel T; Wild PS; Blettner M; Lackner KJ; Pfeiffer N; Beutel ME; Blankenberg S; Westermann D
    Eur Heart J; 2016 Jun; 37(23):1807-14. PubMed ID: 27055814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study.
    Granegger M; Gross C; Siemer D; Escher A; Sandner S; Schweiger M; Laufer G; Zimpfer D
    Sci Rep; 2022 Apr; 12(1):5761. PubMed ID: 35388023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.